Hims & Hers Health delivered a misunderstood Q1-26, raising FY-26 guidance and reaffirming 2030 revenue and EBITDA targets.
The accelerated pace of product launches, integrations, and partner activity positions eGain for further competitive ...
Good afternoon, and thank you all for joining our Earnings Call today. If you have not seen the earnings release, as always, a copy is posted in the financial section of the Investor Relations website ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results